Impfstoffe gegen die Virushepatitiden A bis E. Was haben sie bewirkt, was können sie bewirken?
Author:
- 30 December 2010
- journal article
- review article
- Published by Wiley in Pharmazie in unserer Zeit
- Vol. 40 (1) , 36-43
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hepatitis A Vaccine versus Immune Globulin for Postexposure ProphylaxisNew England Journal of Medicine, 2007
- Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During InfancyPediatrics, 2007
- The Risk of Acquiring Hepatitis A and B Among Travelers in Selected Eastern and Southern Europe and Non‐European Mediterranean Countries: Review and Consensus Statement on Hepatitis A and B VaccinationJournal of Travel Medicine, 2007
- Safety and Efficacy of a Recombinant Hepatitis E VaccineNew England Journal of Medicine, 2007
- Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccinationVaccine, 2006
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000
- Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicityJournal of Medical Virology, 1994
- Decline of anti-HBs after hepatitis B vaccination and timing of revaccinationThe Lancet, 1990
- Four-year experience with a recombinant hepatitis B vaccineInfection, 1989
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988